Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Pzena Investment Management LLC

Pzena Investment Management LLC lessened its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 1.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 965,733 shares of the company's stock after selling 17,580 shares during the period. Pzena Investment Management LLC owned 0.79% of Henry Schein worth $66,143,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in HSIC. Proficio Capital Partners LLC purchased a new position in Henry Schein in the 4th quarter worth about $943,000. HighTower Advisors LLC grew its holdings in Henry Schein by 242.9% during the 4th quarter. HighTower Advisors LLC now owns 43,347 shares of the company's stock worth $3,000,000 after acquiring an additional 30,706 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in Henry Schein by 7.2% during the 4th quarter. Sequoia Financial Advisors LLC now owns 6,109 shares of the company's stock worth $423,000 after acquiring an additional 412 shares in the last quarter. Thrivent Financial for Lutherans grew its holdings in Henry Schein by 10.8% during the 4th quarter. Thrivent Financial for Lutherans now owns 116,843 shares of the company's stock worth $8,085,000 after acquiring an additional 11,428 shares in the last quarter. Finally, Xponance Inc. grew its holdings in Henry Schein by 1.7% during the 4th quarter. Xponance Inc. now owns 19,240 shares of the company's stock worth $1,331,000 after acquiring an additional 315 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Performance

Shares of Henry Schein stock traded down $0.40 during midday trading on Friday, hitting $69.10. The company had a trading volume of 1,177,871 shares, compared to its average volume of 1,742,467. The stock has a market cap of $8.41 billion, a price-to-earnings ratio of 21.59, a PEG ratio of 2.24 and a beta of 0.87. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. The company has a fifty day simple moving average of $71.80 and a 200 day simple moving average of $71.32. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the firm posted $1.10 EPS. Henry Schein's revenue was down .1% on a year-over-year basis. As a group, analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HSIC. Leerink Partners set a $75.00 target price on shares of Henry Schein in a report on Monday. Wells Fargo & Company dropped their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Evercore ISI raised their price target on shares of Henry Schein from $72.00 to $78.00 and gave the company an "in-line" rating in a report on Wednesday, July 9th. Finally, Robert W. Baird restated a "neutral" rating and issued a $72.00 price target (down from $82.00) on shares of Henry Schein in a report on Monday. Eight investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $78.36.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.